CSBR — Champions Oncology Balance Sheet
0.000.00%
Last trade - 00:00- $89.83m
- $80.26m
- $56.94m
- 80
- 57
- 73
- 80
Annual balance sheet for Champions Oncology, fiscal year end - April 30th, USD millions except per share, conversion factor applied.
2021 April 30th | 2022 April 30th | 2023 April 30th | 2024 April 30th | 2025 April 30th | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 4.69 | 9.01 | 10.1 | 2.62 | 9.79 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 6.99 | 9.51 | 8.01 | 9.53 | 11.2 |
| Prepaid Expenses | |||||
| Total Current Assets | 12.6 | 19.7 | 19.5 | 13.6 | 22.4 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 14.6 | 15.4 | 14.5 | 12 | 9.46 |
| Net Goodwill | |||||
| Other Long Term Assets | |||||
| Total Assets | 27.6 | 35.4 | 34.3 | 26.1 | 32.3 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 11.2 | 17.5 | 21.7 | 21.5 | 23.9 |
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 20.2 | 26.3 | 29.7 | 28 | 28.6 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| Total Equity | 7.43 | 9.1 | 4.64 | -1.9 | 3.77 |
| Total Liabilities & Shareholders' Equity | 27.6 | 35.4 | 34.3 | 26.1 | 32.3 |
| Total Common Shares Outstanding |